Relating to the Review of Independent Charity PAP Arrangements. i. a list of the Independent Charity PAPs with which Insys entered charitable donation arrangements during the Reporting Period; ii. for each Independent Charity PAP for which the IRO reviewed arrangements or interactions during the Reporting Period: (a) a description of the review conducted by XXX; and (b) a summary of all instances in which it appears that Insys failed to follow its policies and procedures and/or OIG guidance regarding its arrangements or interactions with an Independent Charity PAP; iii. for each Independent Charity PAP reviewed by the IRO, findings regarding each element specified in Section III.E above; iv. the findings and supporting rationale regarding any overall weaknesses in Insys’s systems, processes, policies, procedures, and practices relating to its arrangements and interactions with Independent Charity PAPs; and v. recommendations, if any, for changes in Insys’s systems, processes, policies, procedures, and practices that would correct or address any weaknesses or deficiencies uncovered during the Transactions Review with respect to its arrangements and interactions with Independent Charity PAPs.
Appears in 1 contract
Samples: Corporate Integrity Agreement
Relating to the Review of Independent Charity PAP Arrangements.
i. a list of the Independent Charity PAPs with which Insys Novartis entered charitable donation arrangements during the Reporting Period;
ii. for each Independent Charity PAP for which the IRO reviewed arrangements or interactions during the Reporting Period: (a) a description of the review conducted by XXXIRO; and (b) a summary of all instances in which it appears that Insys Novartis failed to follow its policies and procedures and/or OIG guidance regarding its arrangements or interactions with an Independent Charity PAP;
iii. for each Independent Charity PAP reviewed by the IRO, findings regarding each element specified above in Section III.E III.D above;
iv. the findings and supporting rationale regarding any overall weaknesses in Insys’s Novartis’ systems, processes, policies, procedures, and practices relating to its arrangements and interactions with Independent Charity PAPs; andand
v. recommendations, if any, for changes in Insys’s Novartis’ systems, processes, policies, procedures, and practices that would correct or address any weaknesses or deficiencies uncovered during the Transactions Review with respect to its arrangements and interactions with Independent Charity PAPs.PAPs.
Appears in 1 contract
Samples: Corporate Integrity Agreement
Relating to the Review of Independent Charity PAP Arrangements. (if applicable)
i. a list of the Independent Charity PAPs with which Insys Mallinckrodt entered charitable donation arrangements or had interactions during the Reporting Period;
ii. for each Independent Charity PAP for which the IRO reviewed arrangements or interactions during the Reporting Period: (a) a description of the review conducted by XXXIRO; and (b) a summary of all instances in which it appears that Insys Mallinckrodt failed to follow its policies and procedures and/or OIG guidance regarding its arrangements or interactions with an Independent Charity PAP;
iii. for each Independent Charity PAP reviewed by the IRO, findings regarding each element specified above in Section III.E III.D above;
iv. the findings and supporting rationale regarding any overall weaknesses in InsysMallinckrodt’s systems, processes, policies, procedures, and practices relating to its arrangements and interactions with Independent Charity PAPs; andand
v. recommendations, if any, for changes in InsysMallinckrodt’s systems, processes, policies, procedures, and practices that would correct or address any weaknesses or deficiencies uncovered during the Transactions Review with respect to its arrangements and interactions with Independent Charity PAPs.review.
Appears in 1 contract
Samples: Corporate Integrity Agreement
Relating to the Review of Independent Charity PAP Arrangements.
i. a list of the Independent Charity PAPs with which Insys USWM entered charitable donation arrangements or had interactions during the Reporting Period;
ii. for each Independent Charity PAP for which the IRO reviewed arrangements or interactions during the Reporting Period: (a) a description of the review conducted by XXX; and (b) a summary of all instances in which it appears that Insys USWM failed to follow its policies and procedures and/or OIG guidance regarding its arrangements or interactions with an Independent Charity PAP;
iii. for each Independent Charity PAP reviewed by the IRO, findings regarding each element specified above in Section III.E III.D above;
iv. the findings and supporting rationale regarding any overall weaknesses in InsysUSWM’s systems, processes, policies, procedures, and practices relating to its arrangements and interactions with Independent Charity PAPs; and
v. recommendations, if any, for changes in InsysUSWM’s systems, processes, policies, procedures, and practices that would correct or address any weaknesses or deficiencies uncovered during the Transactions Review with respect to its arrangements and interactions with Independent Charity PAPs.
Appears in 1 contract
Samples: Corporate Integrity Agreement